Sangamo Therapeutics Inc (SGMO)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Sangamo Therapeutics Inc Faces Grim Financial Forecast as Revenue Plummets by 92.5%
Sangamo Therapeutics Inc*s Revenue Plummeted in Q3 2023, But Bright Spots Await
Sangamo Therapeutics Inc Soars High with Stunning 459% Revenue Increase in Q1 2023
Deficit higher than a year ago at SGMO over the fiscal fourth quarter of 2022
The company reported that revenue depreciated in single digits, in the most recent fiscal period